Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,331 | -14,090 | -7,193 | -20,814 | -19,764 |
| Depreciation Amortization | N/A | N/A | N/A | 0 | 4,284 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 11,430 |
| Accounts receivable | N/A | N/A | N/A | N/A | 2,816 |
| Accounts payable and accrued liabilities | 781 | -192 | -605 | N/A | 1,494 |
| Other Working Capital | -169 | -772 | -713 | 243 | 11,971 |
| Other Operating Activity | -545 | 349 | 684 | 150 | -4,267 |
| Operating Cash Flow | $-20,264 | $-14,705 | $-7,827 | $-20,421 | $7,964 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 0 | -1,446 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $-1,446 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 115,452 |
| Debt Repayment | N/A | N/A | N/A | N/A | -121,936 |
| Other Financing Activity | 18,989 | 11,023 | 10,982 | 10,926 | 0 |
| Financing Cash Flow | $18,989 | $11,023 | $10,982 | $10,926 | $-6,484 |
| Exchange Rate Effect | N/A | N/A | N/A | 0 | -118 |
| Beginning Cash Position | 12,079 | 12,079 | 12,079 | 21,574 | 1,547 |
| End Cash Position | 10,804 | 8,397 | 15,234 | 12,079 | 1,463 |
| Net Cash Flow | $-1,275 | $-3,682 | $3,155 | $-9,495 | $-84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,264 | -14,705 | -7,827 | -20,421 | 7,964 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -1,522 |
| Free Cash Flow | -20,264 | -14,705 | -7,827 | -20,421 | 6,442 |